From  ||| S:0 E:5 ||| IN
efficacy  ||| S:5 E:14 ||| VBG
to  ||| S:14 E:17 ||| TO
impact ||| S:17 E:23 ||| NN
:  ||| S:23 E:25 ||| :
an  ||| S:25 E:28 ||| DT
advocate ||| S:28 E:36 ||| NN
's  ||| S:36 E:39 ||| POS
agenda  ||| S:39 E:46 ||| NN
for  ||| S:46 E:50 ||| IN
HIV  ||| S:50 E:54 ||| NNP
pre-exposure  ||| S:54 E:67 ||| FW
prophylaxis  ||| S:67 E:79 ||| FW
implementation  ||| S:79 E:95 ||| FW
